Correlation Between Advanced Proteome and Biotron

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Advanced Proteome and Biotron at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Advanced Proteome and Biotron into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Advanced Proteome Therapeutics and Biotron Limited, you can compare the effects of market volatilities on Advanced Proteome and Biotron and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Advanced Proteome with a short position of Biotron. Check out your portfolio center. Please also check ongoing floating volatility patterns of Advanced Proteome and Biotron.

Diversification Opportunities for Advanced Proteome and Biotron

0.0
  Correlation Coefficient

Pay attention - limited upside

The 3 months correlation between Advanced and Biotron is 0.0. Overlapping area represents the amount of risk that can be diversified away by holding Advanced Proteome Therapeutics and Biotron Limited in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Biotron Limited and Advanced Proteome is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Advanced Proteome Therapeutics are associated (or correlated) with Biotron. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Biotron Limited has no effect on the direction of Advanced Proteome i.e., Advanced Proteome and Biotron go up and down completely randomly.

Pair Corralation between Advanced Proteome and Biotron

Assuming the 90 days horizon Advanced Proteome Therapeutics is expected to under-perform the Biotron. But the pink sheet apears to be less risky and, when comparing its historical volatility, Advanced Proteome Therapeutics is 8.37 times less risky than Biotron. The pink sheet trades about -0.06 of its potential returns per unit of risk. The Biotron Limited is currently generating about 0.04 of returns per unit of risk over similar time horizon. If you would invest  2.06  in Biotron Limited on August 28, 2024 and sell it today you would lose (0.81) from holding Biotron Limited or give up 39.32% of portfolio value over 90 days.
Time Period3 Months [change]
DirectionFlat 
StrengthInsignificant
Accuracy100.0%
ValuesDaily Returns

Advanced Proteome Therapeutics  vs.  Biotron Limited

 Performance 
       Timeline  
Advanced Proteome 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Advanced Proteome Therapeutics has generated negative risk-adjusted returns adding no value to investors with long positions. Despite nearly stable fundamental indicators, Advanced Proteome is not utilizing all of its potentials. The newest stock price disturbance, may contribute to mid-run losses for the stockholders.
Biotron Limited 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Biotron Limited has generated negative risk-adjusted returns adding no value to investors with long positions. Despite fragile performance in the last few months, the Stock's basic indicators remain nearly stable which may send shares a bit higher in December 2024. The current disturbance may also be a sign of long-run up-swing for the company stockholders.

Advanced Proteome and Biotron Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Advanced Proteome and Biotron

The main advantage of trading using opposite Advanced Proteome and Biotron positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Advanced Proteome position performs unexpectedly, Biotron can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Biotron will offset losses from the drop in Biotron's long position.
The idea behind Advanced Proteome Therapeutics and Biotron Limited pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Content Syndication module to quickly integrate customizable finance content to your own investment portal.

Other Complementary Tools

Pattern Recognition
Use different Pattern Recognition models to time the market across multiple global exchanges
Alpha Finder
Use alpha and beta coefficients to find investment opportunities after accounting for the risk
Funds Screener
Find actively-traded funds from around the world traded on over 30 global exchanges
Money Managers
Screen money managers from public funds and ETFs managed around the world
USA ETFs
Find actively traded Exchange Traded Funds (ETF) in USA